Clinical trial
Using CTA Measures to Define Cardiac Risk In NFL Alumni
NCT06831409 is registered in ClinicalTrials.gov with HeartFlow, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Using CTA Measures to Define Cardiac Risk In NFL Alumni
- Lead sponsor
- HeartFlow, Inc.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 17, 2024
- Completion date
- December 31, 2026
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery disease (cad), coronary atherosclerosis, heart disease